PRESS
HOME
      PR
      PharmaResearch Accelerates Global Market Expansion with Investment from Global Private Equity Fund CVC

      2024. 09. 05
      PR
      PharmaResearch Hosts 'Open Innovation Day'

      2024. 08. 14
      PR
      PharmaResearch Hosts Launch Symposium for REJURAN Registered HB Plus in Singapore

      2024. 07. 09
      PR
      PharmaResearch, "Rejuran®" Accelerates Entry into Vietnam

      2024. 05. 21
      PR
      PharmaResearch 'REJURAN®HB Plus' Medical Device Addresses Skin Concerns and Reduces Pain

      2024. 04. 09
      PR
      PharmaResearch to present the research on its nano anti-cancer drug PRD-101 at the AACR Annual Meeting 2024

      2024. 03. 22
      PR
      PharmaResearch acquires product approval for CONJURAN in Malaysia

      2024. 03. 11
      PR
      Introducing REJURAN® Triple Radiance Ampoule

      2024. 03. 11
      PR
      PharmaResearch Participates in 'IMCAS PARIS 2024' with Rejuran®… Stepping into the European Market in Earnest

      2024. 02. 07
      PR
      PharmaResearch Hosts the 4th Global Symposium

      2023. 11. 03